Literature DB >> 1323836

Molecular cloning and characterization of an adenosine receptor: the A3 adenosine receptor.

Q Y Zhou1, C Li, M E Olah, R A Johnson, G L Stiles, O Civelli.   

Abstract

We have previously reported the selective amplification of several rat striatal cDNA sequences that encode guanine nucleotide-binding regulatory protein (G protein)-coupled receptors. One of these sequences (R226) exhibited high sequence identity (58%) with the two previously cloned adenosine receptors. A full-length cDNA clone for R226 has been isolated from a rat brain cDNA library. The cDNA clone encodes a protein of 320 amino acids that can be organized into seven transmembrane stretches. R226 has been expressed in COS-7 and CHO cells and membranes from the transfected cells were screened with adenosine receptor radioligands. R226 could bind the nonselective adenosine agonist tritiated N-ethyladenosine 5'-uronic acid ([3H]NECA) and A1-selective agonist radioiodinated N6-2-(4-amino-3-iodophenyl)-ethyladenosine ([125I]APNEA) but not A1-selective antagonists tritiated 1,3-dipropyl-8-cyclopentylxanthine ([3H]DPCPX) and 8-(4-[([[(2-aminoethyl)amino]carbonyl]methyl)oxy]-phenyl)-1, 3-dipropylxanthine ([3H]XAC) or the A2-selective agonist ligands tritiated 2-[4-(2-carboxyethyl)phenyl]ethyl-amino 5'-N-ethylcarboxamidoadenosine ([3H]CGS21680) and radioiodinated 2-[4-([2-[(4-aminophenyl)methylcarbonylamino] ethylaminocarbonyl]ethyl)phenyl]ethylamino 5'-N-ethylcarboxamidoadenosine. Extensive characterization with [125I]APNEA showed that R226 binds [125I]APNEA with high affinity (Kd = 15.5 +/- 2.4 nM) and the specific [125I]APNEA binding could be inhibited by adenosine ligands with a potency order of (R)-N6-phenyl-2-propyladenosine (R-PIA) = NECA greater than S-PIA greater than adenosine greater than ATP = ADP but not by antagonists XAC, isobutylmethylxanthine, and DPCPX. In R226 stably transfected CHO cells, adenosine agonists R-PIA, NECA, and CGS21680 inhibited by 40-50% the forskolin-stimulated cAMP accumulation through a pertussis toxin-sensitive G protein with an EC50 of 18 +/- 5.6 nM, 23 +/- 3.5 nM, and 144 +/- 34 nM, respectively. Based on these observations we conclude that R226 encodes an adenosine receptor with non-A1 and non-A2 specificity, and we thus name it the A3 adenosine receptor. mRNA analyses revealed that the highest expression of R226 was in the testis and low-level mRNAs were also found in the lung, kidneys, heart, and some parts of the central nervous system such as cortex, striatum, and olfactory bulb. The high-expression level of the A3 receptor in the testis suggests a possible role for adenosine in reproduction.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1323836      PMCID: PMC49724          DOI: 10.1073/pnas.89.16.7432

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  26 in total

1.  Molecular cloning and characterization of a rat A1-adenosine receptor that is widely expressed in brain and spinal cord.

Authors:  S M Reppert; D R Weaver; J H Stehle; S A Rivkees
Journal:  Mol Endocrinol       Date:  1991-08

Review 2.  Molecular biology of the dopamine receptors.

Authors:  O Civelli; J R Bunzow; D K Grandy; Q Y Zhou; H H Van Tol
Journal:  Eur J Pharmacol       Date:  1991-08-14       Impact factor: 4.432

3.  Distinct pathways of desensitization of A1- and A2-adenosine receptors in DDT1 MF-2 cells.

Authors:  V Ramkumar; M E Olah; K A Jacobson; G L Stiles
Journal:  Mol Pharmacol       Date:  1991-11       Impact factor: 4.436

4.  High-efficiency transformation of mammalian cells by plasmid DNA.

Authors:  C Chen; H Okayama
Journal:  Mol Cell Biol       Date:  1987-08       Impact factor: 4.272

5.  2-Chloroadenosine decreases tyrosylprotein sulfotransferase activity in the Golgi apparatus in PC12 cells. Evidence for a novel receptor.

Authors:  W H Lin; K A Marcucci; R A Rabin; J A Roth
Journal:  J Biol Chem       Date:  1991-08-05       Impact factor: 5.157

6.  Adenosine inhibits histamine-induced phosphoinositide hydrolysis mediated via pertussis toxin-sensitive G protein in human astrocytoma cells.

Authors:  N Nakahata; M T Abe; I Matsuoka; T Ono; H Nakanishi
Journal:  J Neurochem       Date:  1991-09       Impact factor: 5.372

7.  Cloning and expression of an A1 adenosine receptor from rat brain.

Authors:  L C Mahan; L D McVittie; E M Smyk-Randall; H Nakata; F J Monsma; C R Gerfen; D R Sibley
Journal:  Mol Pharmacol       Date:  1991-07       Impact factor: 4.436

8.  The A2 adenosine receptor: guanine nucleotide modulation of agonist binding is enhanced by proteolysis.

Authors:  C Nanoff; K A Jacobson; G L Stiles
Journal:  Mol Pharmacol       Date:  1991-02       Impact factor: 4.436

9.  Solubilized rat brain adenosine receptors have two high-affinity binding sites for 1,3-dipropyl-8-cyclopentylxanthine.

Authors:  J C Oliveira; A M Sebastião; J A Ribeiro
Journal:  J Neurochem       Date:  1991-10       Impact factor: 5.372

10.  The orphan receptor cDNA RDC7 encodes an A1 adenosine receptor.

Authors:  F Libert; S N Schiffmann; A Lefort; M Parmentier; C Gérard; J E Dumont; J J Vanderhaeghen; G Vassart
Journal:  EMBO J       Date:  1991-07       Impact factor: 11.598

View more
  156 in total

1.  Adenosine A3 receptors on human eosinophils mediate inhibition of degranulation and superoxide anion release.

Authors:  C I Ezeamuzie; E Philips
Journal:  Br J Pharmacol       Date:  1999-05       Impact factor: 8.739

2.  Dominance of G(s) in doubly G(s)/G(i)-coupled chimaeric A(1)/A(2A) adenosine receptors in HEK-293 cells.

Authors:  A L Tucker; L G Jia; D Holeton; A J Taylor; J Linden
Journal:  Biochem J       Date:  2000-11-15       Impact factor: 3.857

3.  Pharmacological and biochemical characterization of A3 adenosine receptors in Jurkat T cells.

Authors:  S Gessi; K Varani; S Merighi; A Morelli; D Ferrari; E Leung; P G Baraldi; G Spalluto; P A Borea
Journal:  Br J Pharmacol       Date:  2001-09       Impact factor: 8.739

Review 4.  Mast cells. Receptors, secretagogues, and signaling.

Authors:  Bhavya B Sharma; John R Apgar; Fu-Tong Liu
Journal:  Clin Rev Allergy Immunol       Date:  2002-04       Impact factor: 8.667

5.  Identification by site-directed mutagenesis of residues involved in ligand recognition and activation of the human A3 adenosine receptor.

Authors:  Zhan-Guo Gao; Aishe Chen; Dov Barak; Soo-Kyung Kim; Christa E Müller; Kenneth A Jacobson
Journal:  J Biol Chem       Date:  2002-03-12       Impact factor: 5.157

6.  Overexpression of A(3) adenosine receptors decreases heart rate, preserves energetics, and protects ischemic hearts.

Authors:  Heather R Cross; Elizabeth Murphy; Richard G Black; John Auchampach; Charles Steenbergen
Journal:  Am J Physiol Heart Circ Physiol       Date:  2002-06-20       Impact factor: 4.733

7.  Characterization of the adenosine receptor mediating contraction in rat colonic muscularis mucosae.

Authors:  J J Reeves; J Coates; J E Jarvis; M J Sheehan; P Strong
Journal:  Br J Pharmacol       Date:  1993-11       Impact factor: 8.739

8.  Adenosine receptor-mediated modulation of acetylcholine release from rat striatal synaptosomes.

Authors:  K A Kirkpatrick; P J Richardson
Journal:  Br J Pharmacol       Date:  1993-11       Impact factor: 8.739

9.  Selective ligands for rat A3 adenosine receptors: structure-activity relationships of 1,3-dialkylxanthine 7-riboside derivatives.

Authors:  H O Kim; X D Ji; N Melman; M E Olah; G L Stiles; K A Jacobson
Journal:  J Med Chem       Date:  1994-11-11       Impact factor: 7.446

10.  Coupling of a transfected human brain A1 adenosine receptor in CHO-K1 cells to calcium mobilisation via a pertussis toxin-sensitive mechanism.

Authors:  P A Iredale; S P Alexander; S J Hill
Journal:  Br J Pharmacol       Date:  1994-04       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.